FilingReader Intelligence

CQ Pharmaceutical now faces 377m yuan asset impairment charges

August 20, 2025 at 09:42 AM UTCBy FilingReader AI

CQ Pharmaceutical Holdings set aside 377.4 million yuan for asset impairment losses in the first half of 2025, including 374.4 million yuan for credit impairment losses and 2.9 million yuan for inventory impairment.

The provisions will reduce the company's net profit and owner's equity by 196.8 million yuan for the period.

This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com

News Alerts

Get instant email alerts when CQ Pharmaceutical Holding publishes news

Free account required • Unsubscribe anytime

Filing Activity Timeline

View Complete Filing History →